Raynaud's Syndrome Completed Phase 2 / 3 Trials for Sildenafil (DB00203)

Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud's syndrome NOS / Raynauds' phen / Raynaud Disease

IndicationStatusPhase
DBCOND0049133 (Raynaud's Syndrome)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02050360As Required Oral Sildenafil in Raynaud's PhenomenonTreatment